Showing posts with label generic drugs. Show all posts
Showing posts with label generic drugs. Show all posts

Tuesday, December 23, 2025

The FDA Often Doesn’t Test the Quality of Generic Drugs, So We Did — ProPublica

ProPublica tested several versions of widely prescribed generic drugs and found two samples with irregularities that experts say could compromise their effectiveness…


Friday, December 8, 2023

Opinion | Why We’re Stuck in a Constant Cycle of Drug Shortages - The New York Times

The problem is that the generic drug system is built to be fragile. Manufacturers compete against one another for orders from price-conscious health care providers, cutting costs where they can to offer the lowest prices. This leads to a race to the bottom of minimum accepted standards, including a lack of investment in quality systems and limited redundancy...

Monday, January 13, 2020

California plans to launch own prescription drug label | TheHill

California wants to become the first state to create its own prescription drug label, Gov. Gavin Newsom (D) announced Thursday morning. As part of his 2020-2021 budget, Newsom wants to create the first-ever state generic drug label as part of a series of sweeping proposals designed to lower the cost of health care in the Golden State. He also wants public and private insurers to negotiate drug prices together to leverage lower prices.....
https://thehill.com/policy/healthcare/477494-california-plans-to-launch-own-prescription-drug-label

Thursday, December 12, 2019

Yang pitches public manufacturing of generic drugs | TheHill

Entrepreneur Andrew Yang on Tuesday released a plan to lower prescription drug costs, which includes allowing Medicare to negotiate drug prices and creating public manufacturing facilities to make generic drugs.
https://thehill.com/policy/healthcare/medical-devices-and-prescription-drug-policy/473834-yang-pitches-public

Thursday, May 23, 2019

Bottle of Lies: How Poor FDA Oversight & Fraud in Generic Drug Industry Threaten Patients' Health

Generic drugs amount to 90% of all prescriptions filled in the U.S., most of them made in plants in India and China. Generic drugs can be more affordable, but in her new explosive book “Bottle of Lies: The Inside Story of the Generic Drug Boom,” investigative journalist Katherine Eban works with two industry whistleblowers to expose how some manufacturers are cutting corners at the cost of quality and safety. This comes as the U.S. Food and Drug Administration just issued its own update on the state of pharmaceutical quality that found the drug quality of factories in India and China scored below the world average. FDA officials say that’s because more robust inspections have uncovered problems and that “the quality of the drug supply has never been higher.” ...
Interview:
https://youtu.be/lCrTuT5ywvI

Thursday, April 19, 2018

Drug Lobbying Pays Off Yet Again - Mother Jones

In order to earn FDA approval for generic drugs, manufacturers need samples of the name-brand drug to test against. Frequently, however, the name-brand folks refuse to sell their pills for testing. Congress is on the case: ....
https://www.motherjones.com/kevin-drum/2018/04/drug-lobbying-pays-off-yet-again/







Click Older Posts above to see more.